Funded Grants

PI Name	PI Organization	Title	Grant Number	Initiative	Program Official Sort descending
Maldonado, Fabien	Vanderbilt University Medical Center United States	Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures	5R01CA253923-04		Richard Mazurchuk, Ph.D.
Balu, Mihaela	University Of California-Irvine United States	Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma	5R01CA259019-02	PAR-20-155 (R01 Clinical Trial Optional)	Richard Mazurchuk, Ph.D.
Heine, John J	H. Lee Moffitt Cancer Ctr & Res Inst United States	Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center	2U01CA200464-06A1		Richard Mazurchuk, Ph.D.
Grimm, Lars J	Duke University United States	Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications	5R01CA271237-02	PAR-19-264 (R01 Clinical Trial Optional)	Richard Mazurchuk, Ph.D.
Lin, Jia-Ren	Harvard Medical School United States	Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images	5R50CA274277-02		Richard Mazurchuk, Ph.D.
Largaespada, David Andrew	University Of Minnesota United States	Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention	5UH3CA244687-05		Mark Steven Miller, Ph.D.
Zhang, Fan	University Of Florida United States	NCI Diversity Supplement	3R21CA277263-02S1		Mark Steven Miller, Ph.D.
Largaespada, David Andrew	University Of Minnesota United States	Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention	5UH3CA244687-05		Mark Steven Miller, Ph.D.
Demehri, Shadmehr	Massachusetts General Hospital United States	Epithelium-derived alarmins role in breast cancer immunoprevention	5U01CA233097-05		Mark Steven Miller, Ph.D.
Altorki, Nasser Khaled	Weill Medical Coll Of Cornell Univ United States	Intercepting progression from pre-invasive to invasive lung adenocarcinoma	3UH3CA244697-05S1		Mark Steven Miller, Ph.D.